Question 3 Should carbamazepine be administered to manage agitation and aggressive behaviour following paediatric acquired brain injury? | Archives of Disease in Childhood

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via RCPCH

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article info

Miscellania

Archimedes

Question 3 Should carbamazepine be administered to manage agitation and aggressive behaviour following paediatric acquired brain injury?

Authors

Emma Waters PubMed articles Google scholar articles
Matthew C H J Morrall PubMed articles Google scholar articles
Deborah Murdoch-Eaton PubMed articles Google scholar articles

Correspondence to Matthew C H J Morrall, Paediatric Neuropsychology, The Leeds Teaching Hospitals NHS Trust, Leeds, UK; matthew.morrall{at}leedsth.nhs.uk

Citation

Waters E, Morrall MCHJ, Murdoch-Eaton D

Question 3 Should carbamazepine be administered to manage agitation and aggressive behaviour following paediatric acquired brain injury?

Archives of Disease in Childhood 2010;95:950-952.

Publication history

First published October 26, 2010.

Online issue publication

March 22, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions